736 related articles for article (PubMed ID: 23891805)
1. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
[TBL] [Abstract][Full Text] [Related]
2. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
3. Drug screening for ALS using patient-specific induced pluripotent stem cells.
Egawa N; Kitaoka S; Tsukita K; Naitoh M; Takahashi K; Yamamoto T; Adachi F; Kondo T; Okita K; Asaka I; Aoi T; Watanabe A; Yamada Y; Morizane A; Takahashi J; Ayaki T; Ito H; Yoshikawa K; Yamawaki S; Suzuki S; Watanabe D; Hioki H; Kaneko T; Makioka K; Okamoto K; Takuma H; Tamaoka A; Hasegawa K; Nonaka T; Hasegawa M; Kawata A; Yoshida M; Nakahata T; Takahashi R; Marchetto MC; Gage FH; Yamanaka S; Inoue H
Sci Transl Med; 2012 Aug; 4(145):145ra104. PubMed ID: 22855461
[TBL] [Abstract][Full Text] [Related]
4. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R
Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555
[TBL] [Abstract][Full Text] [Related]
5. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
6. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
[TBL] [Abstract][Full Text] [Related]
7. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
[TBL] [Abstract][Full Text] [Related]
8. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons.
Ratti A; Gumina V; Lenzi P; Bossolasco P; Fulceri F; Volpe C; Bardelli D; Pregnolato F; Maraschi A; Fornai F; Silani V; Colombrita C
Neurobiol Dis; 2020 Nov; 145():105051. PubMed ID: 32827688
[TBL] [Abstract][Full Text] [Related]
9. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent.
Fujimori K; Ishikawa M; Otomo A; Atsuta N; Nakamura R; Akiyama T; Hadano S; Aoki M; Saya H; Sobue G; Okano H
Nat Med; 2018 Oct; 24(10):1579-1589. PubMed ID: 30127392
[TBL] [Abstract][Full Text] [Related]
10. Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis.
Seminary ER; Santarriaga S; Wheeler L; Mejaki M; Abrudan J; Demos W; Zimmermann MT; Urrutia RA; Fee D; Barkhaus PE; Ebert AD
Cells; 2020 Feb; 9(3):. PubMed ID: 32121108
[TBL] [Abstract][Full Text] [Related]
11. ALS, a cellular whodunit on motor neuron degeneration.
Karagiannis P; Inoue H
Mol Cell Neurosci; 2020 Sep; 107():103524. PubMed ID: 32629110
[TBL] [Abstract][Full Text] [Related]
12. iPSC motor neurons, but not other derived cell types, capture gene expression changes in postmortem sporadic ALS motor neurons.
Held A; Adler M; Marques C; Reyes CJ; Kavuturu AS; Quadros ARAA; Ndayambaje IS; Lara E; Ward M; Lagier-Tourenne C; Wainger BJ
Cell Rep; 2023 Sep; 42(9):113046. PubMed ID: 37651231
[TBL] [Abstract][Full Text] [Related]
13. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
[TBL] [Abstract][Full Text] [Related]
14. Downstream Effects of Mutations in
Dash BP; Freischmidt A; Weishaupt JH; Hermann A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077049
[TBL] [Abstract][Full Text] [Related]
15. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons.
Namboori SC; Thomas P; Ames R; Hawkins S; Garrett LO; Willis CRG; Rosa A; Stanton LW; Bhinge A
Stem Cell Reports; 2021 Dec; 16(12):3020-3035. PubMed ID: 34767750
[TBL] [Abstract][Full Text] [Related]
17. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
Imamura K; Izumi Y; Watanabe A; Tsukita K; Woltjen K; Yamamoto T; Hotta A; Kondo T; Kitaoka S; Ohta A; Tanaka A; Watanabe D; Morita M; Takuma H; Tamaoka A; Kunath T; Wray S; Furuya H; Era T; Makioka K; Okamoto K; Fujisawa T; Nishitoh H; Homma K; Ichijo H; Julien JP; Obata N; Hosokawa M; Akiyama H; Kaneko S; Ayaki T; Ito H; Kaji R; Takahashi R; Yamanaka S; Inoue H
Sci Transl Med; 2017 May; 9(391):. PubMed ID: 28539470
[TBL] [Abstract][Full Text] [Related]
18. Specific vulnerability of iPSC-derived motor neurons with TDP-43 gene mutation to oxidative stress.
Onda-Ohto A; Hasegawa-Ogawa M; Matsuno H; Shiraishi T; Bono K; Hiraki H; Kanegae Y; Iguchi Y; Okano HJ
Mol Brain; 2023 Jul; 16(1):62. PubMed ID: 37496071
[TBL] [Abstract][Full Text] [Related]
19. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD.
Dafinca R; Barbagallo P; Farrimond L; Candalija A; Scaber J; Ababneh NA; Sathyaprakash C; Vowles J; Cowley SA; Talbot K
Stem Cell Reports; 2020 May; 14(5):892-908. PubMed ID: 32330447
[TBL] [Abstract][Full Text] [Related]
20. [ALS disease modeling and drug screening using patient-specific iPS cells].
Egawa N; Inoue H
Rinsho Shinkeigaku; 2013; 53(11):1020-2. PubMed ID: 24291866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
